Jenny Chen, Ph.D.

Subscribe to Jenny Chen, Ph.D.'s Posts
Jenny Chen, Ph.D. counsels both US and international clients in a wide-array of patent-related matters in the life science space, including prosecution, opinion, due diligence, licensing and post-grant proceedings. Her practice focuses on matters including antibodies, cell therapies, gene therapies, small molecule therapeutics, diagnosis and pharmaceutical formulations. Read Jenny Chen's full bio.

Post-AIA Patents Are Not Shielded from Interferences

By on Dec 16, 2021
Posted In Patents

Addressing the applicability of interference proceedings to patent applications filed after the Leahy-Smith America Invents Act (AIA) was enacted, the Patent Trial & Appeal Board (Board) found it proper to declare an interference between a patent application with a priority date before March 16, 2013, the AIA implementation date, and a patent with a priority...

Continue Reading

It’s Not Esoteric: Absent Ambiguity, Plain Contractual Language Governs

By on Nov 4, 2021
Posted In Patents

Rudimentary principles of contract law stipulate that words in a contract that are plain and free from ambiguity must be understood in their usual and ordinary sense. Applying such principles, the US Court of Appeals for the First Circuit vacated a district court’s damages award of more than $1 million under a patent license agreement,...

Continue Reading

Inventions Not Made Under Employment Agreement

By on Apr 22, 2021
Posted In Patents, Trade Secrets

Applying a “middle ground” standard of review, the US Court of Appeals for the First Circuit affirmed a district court’s decision denying a company’s request for a declaratory judgment asking a former employee to assign patent rights to the company under the employment and separation agreements, because there were inconsistencies in the jury verdict. Covidien...

Continue Reading